Alembic Pharmaceuticals jumped 6% to Rs 622.80 at 15:15 IST on BSE after consolidated net profit jumped 281.38% to Rs 269.49 crore on 80.6% rise in total income to Rs 924.53 crore in Q3 December 2015 over Q3 December 2014.
The result was announced during market hours today, 21 January 2016.Meanwhile, the BSE Sensex was down 121.89 points, or 0.51%, to 23,940.15.
More than usual volumes were witnessed on the counter. On BSE, so far 66,244 shares were traded in the counter, compared with an average volume of 20,412 shares in the past one quarter. The stock hit a high of Rs 631 and a low of Rs 601.05 so far during the day. The stock hit a record high of Rs 791.70 on 15 July 2015. The stock hit a 52-week low of Rs 381.90 on 26 February 2015.
Alembic Pharmaceuticals said that sales from India branded business rose 15% to Rs 288 crore in Q3 December 2015 over Q3 December 2014. Sales from international business jumped 248% to Rs 521 crore in Q3 December 2015 over Q3 December 2014. Sales from active pharmaceutical ingredients (API) business rose 24% to Rs 101 crore in Q3 December 2015 over Q3 December 2014.
Alembic Pharmaceuticals is a leading pharmaceutical company.
Powered by Capital Market - Live News
